ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$BIIB:NASDAQ · BIOGEN INC

Sector: health

Conviction from: NASDAQS&P

52-week range: 135.39226.43

Biogen is a biopharmaceutical company focused on neuroscience, developing treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease.

3 tracked filer(s) hold this · 0 opened, 1 added, 2 trimmed in 30-JUN-2026

Aggregate 13FScore 60 — mean of 3 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor63Added +336%4,800$1,037,0880.0%
Ancora40Trimmed -83%39$8,4260.0%
Steve Cohen / Point7276Trimmed -89%88,749$19,175,1090.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-03-27Alan Armstrong senateBUY$1,001 - $15,000PTR

Trump & executive branch trades all Trump/exec trades →

4 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-08-22Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.